老虎證券

美股詳情
本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

enVVeno Medical Corp.

3.55
+0.24007.25%
盤後：3.620.0694+1.95%19:52 EDT
成交量：19.98萬
成交額：71.07萬
市值：6,225.26萬
市盈率：-2.79
高：3.73
開：3.40
低：3.29
收：3.31
資料載入中...
總覽公司新聞公告
2021/02/05

[修訂]招股説明書

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2021/02/05

[補充]招股説明書

FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2021/02/05

SEC問詢函

CORRESP [Cover] - Correspondence
2021/02/05

SEC問詢函

CORRESP [Cover] - Correspondence
2021/02/04

SEC問詢函

CORRESP [Cover] - Correspondence
2021/02/03

[修訂]招股説明書

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2021/02/03

SEC問詢函

CORRESP [Cover] - Correspondence
2021/02/03

SEC問詢函

CORRESP [Cover] - Correspondence
2021/01/29

[補充]招股説明書

FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2021/01/29

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/01/28

[修訂]招股説明書

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2021/01/20

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2020/12/21

招股説明書

S-1 - General form for registration of securities under the Securities Act of 1933
2020/12/21

重要事件披露

8-K - Current report
2020/12/18

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2020/12/16

超過5%披露

SC 13D - General statement of acquisition of beneficial ownership
2020/12/02

重要事件披露

8-K - Current report
2020/11/27

SEC問詢函

CORRESP [Cover] - Correspondence
2020/11/24

[修訂]招股説明書

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2020/11/24

重要事件披露

8-K - Current report
更多